AMED Amedisys Inc

Price (delayed)

$156.14

Market cap

$5.1B

P/E Ratio

20.65

Dividend/share

N/A

EPS

$7.56

Enterprise value

$5.29B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The net income has soared by 93% YoY and by 23% QoQ
AMED's EPS has soared by 90% YoY and by 23% from the previous quarter
The quick ratio has decreased by 14% YoY but it has increased by 6% QoQ

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.63M
Market cap
$5.1B
Enterprise value
$5.29B
Valuations
Price to earnings (P/E)
20.65
Price to book (P/B)
5.82
Price to sales (P/S)
2.32
EV/EBIT
17.11
EV/EBITDA
13.89
EV/Sales
2.41
Earnings
Revenue
$2.2B
EBIT
$308.93M
EBITDA
$380.62M
Free cash flow
$264.42M
Per share
EPS
$7.56
Free cash flow per share
$8.11
Book value per share
$26.84
Revenue per share
$67.39
TBVPS
$18.3
Balance sheet
Total assets
$1.6B
Total liabilities
$723.68M
Debt
$283.62M
Equity
$874.27M
Working capital
-$58.26M
Liquidity
Debt to equity
0.32
Current ratio
0.87
Quick ratio
0.83
Net debt/EBITDA
0.5
Margins
EBITDA margin
17.3%
Gross margin
44.9%
Net margin
11.3%
Operating margin
12.4%
Efficiency
Return on assets
15.6%
Return on equity
30.6%
Return on invested capital
83.8%
Return on capital employed
26.9%
Return on sales
14.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
0.51%
1 week
-6.88%
1 month
-12.06%
1 year
-32.81%
YTD
-46.77%
QTD
-36.25%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.2B
Gross profit
$985.79M
Operating income
$272.45M
Net income
$247.15M
Gross margin
44.9%
Net margin
11.3%
The net income has soared by 93% YoY and by 23% QoQ
The company's net margin has surged by 74% YoY and by 19% QoQ
AMED's operating income is up by 50% year-on-year and by 12% since the previous quarter
The company's operating margin rose by 35% YoY and by 8% QoQ

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
20.65
P/B
5.82
P/S
2.32
EV/EBIT
17.11
EV/EBITDA
13.89
EV/Sales
2.41
AMED's EPS has soared by 90% YoY and by 23% from the previous quarter
The P/E is 52% below the last 4 quarters average of 43.4 and 51% below the 5-year quarterly average of 42.3
The P/B is 45% less than the last 4 quarters average of 10.6 and 17% less than the 5-year quarterly average of 7.0
AMED's equity is up by 21% year-on-year and by 11% since the previous quarter
The P/S is 42% less than the last 4 quarters average of 4.0
Amedisys's revenue has increased by 11% YoY and by 3.7% from the previous quarter

Efficiency

How efficient is Amedisys business performance
The ROIC has soared by 136% YoY and by 39% from the previous quarter
The ROA has soared by 70% year-on-year and by 24% since the previous quarter
The ROE has soared by 58% YoY and by 17% from the previous quarter
AMED's ROS has soared by 53% YoY and by 22% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 121% higher than its total liabilities
The company's total liabilities fell by 22% YoY and by 8% QoQ
The current ratio has decreased by 15% YoY but it has increased by 4.8% QoQ
The company's debt is 68% lower than its equity
The debt to equity has plunged by 54% YoY and by 26% from the previous quarter
The company's debt fell by 43% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.